Jobling, Phillip, Jennifer P. Messenger, and Ian L. Gibbins. Differential expression of functionally identified and immunohistochemically identified NK 1 receptors on sympathetic neurons. J Neurophysiol 85: 1888Neurophysiol 85: -1898Neurophysiol 85: , 2001. We have used multiple-labeling immunohistochemistry, intracellular dye-filling, and intracellular microelectrode recordings to characterize the distribution of tachykinin receptors and substance P boutons on subpopulations of neurons within the guinea pig celiac ganglion. Superfusion of substance P (SP, 1 M for 1 min) depolarized 42% of tonic neurons and inhibited afterhyperpolarizations in 66% of long afterhyperpolarizing (LAH) neurons without significant desensitization. Twenty-one percent of tonic neurons and 24% of LAH neurons responded to the NK 3 agonist senktide but did not respond to SP, indicating SP did not activate NK 3 receptors at this concentration. All effects of SP were abolished by the selective NK 1 receptor antagonist, SR140333, but not by the selective NK 3 receptor antagonist, SR142801, suggesting that exogenous SP activated a receptor with NK 1 pharmacology. No dye-filled LAH neuron and only 50% of tonic neurons responding to SP expressed NK 1 receptor immunoreactivity (NK 1 -IR). All neurons responding to SP had SP immunoreactive fibers within one cell diameter, indicating good spatial matching between SP release sites and target neurons. These results indicate that SP may act via a receptor with NK 1 -like pharmacology that has a C terminus not recognized by antibodies to the intracellular domain of the conventional NK 1 receptor. Inward currents evoked by SP acting on this NK 1 -like receptor or senktide acting through NK 3 receptors had identical current-voltage relationships. In LAH neurons, both agonists suppressed I sAHP without reducing I AHP . Responses evoked by SP and senktide were resistant to PKC inhibitors, suggesting that the transduction mechanisms for the NK 1 -like receptor and the NK 3 receptor may be similar.
Within the nervous system of mammals, tachykinins such as substance P (SP) are thought to act via three well-defined subclasses of neurokinin (NK) receptor: NK 1 , NK 2 , and NK 3 receptors (Iversen 1994; Krause et al. 1994) . Classification of NK receptors was based originally on the relative potency of several endogenous and synthetic tachykinin agonists (Regoli et al. 1994) . Subsequent development of specific antagonists and the eventual cloning of three main subtypes of rat and human NK receptor have supported the concept of a restricted number of receptors (Krause et al. 1994) . Although evidence for a short form of the NK 1 receptor has recently surfaced, physiological roles or distributions of this variant within the nervous system have yet to be determined (Fong et al. 1992) Participation of tachykinins in synaptic transmission has been found throughout the nervous system and is present in a wide variety of species. It has been particularly well characterized in the enteric nervous system (Holzer and HolzerPetsche 1997; Johnson et al. 1998) , and spinal cord (Parker and Grillner 1996; Urban et al. 1994) . Within guinea pig prevertebral ganglia, SP is contained in axon collaterals of sensory neurons (Dalsgaard et al. 1983; Kreulen and Peters 1986; Mathews and Cuello 1982, 1984) as well as a subpopulation of preganglionic boutons (Gibbins 1995) . Evidence for the involvement of tachykinins in synaptic transmission within the celiac ganglion was first obtained two decades ago (Konishi et al. 1983; Tsunoo et al. 1982) . More recently, Zhao and colleagues (Zhao et al. 1995 (Zhao et al. , 1996 have elucidated the pharmacological profile of the tachykinin receptors responsible for the effects of both exogenously and endogenously released SP on different electrophysiological classes of neurons within this ganglion. Stimulation of the celiac nerves evoked a depolarization in electrophysiologically defined tonic neurons and inhibition of the afterhyperpolarization in long afterhyperpolarizing (LAH) neurons. Both responses were inhibited by the NK 1 antagonist GR71251 (Zhao et al. 1996) . Furthermore, responses to exogenous SP and neurokinin A (NKA) were also blocked by GR71251, indicating that SP acts via NK 1 receptors in this ganglion and that NK 2 receptors are absent.
We have recently investigated the anatomical distribution of both SP binding sites and NK 1 receptor immunoreactivity within subpopulations of neurons in the guinea pig celiac ganglion (Messenger and Gibbins 1998; Messenger et al. 1999) . In this ganglion, subpopulations of neurons are topographically separated. LAH neurons contain NPY and are preferentially located in the lateral regions of the ganglion, whereas tonic neurons are located medially and contain either somatostatin or no known peptide (Costa and Furness 1984; Gibbins et al. 1999; Keast et al. 1993; Macrae et al. 1986 ). We found that both SP binding and immunoreactivity to NK 1 receptors (NK 1 -IR) occur preferentially on neurons that lack NPY and occur in the medial celiac ganglion; these are likely to be tonic neurons projecting to the gut. In contrast, very few NPY-containing neurons, which occur in the lateral celiac ganglion and project mostly to blood vessels, showed NK 1 -IR (Messenger et al. 1999 ). This differential distribution of immunohistochemically identified NK 1 receptors is in contrast with the pharmacological studies of Zhao et al. (1995 Zhao et al. ( , 1996 , which suggest that NK 1 receptors are found on a majority of both LAH and tonic neurons. To resolve this issue, it is necessary to determine the distribution of functionally and immunohistochemically identified NK 1 receptors on a cell-bycell basis. Therefore we have used a combined pharmacological, electrophysiological, and immunohistochemical approach to investigate the distribution of NK 1 receptors on individual LAH and tonic neurons within the celiac ganglion. As we previously identified a spatial mismatch between NK 1 -IR neurons and SP-IR boutons (Messenger et al. 1999) , we also compared the relationship between neurons which respond to exogenous SP and the distribution of SP-IR nerve fibers.
M E T H O D S
Male or female guinea pigs weighing 160 -350 g were used. The celiac ganglion was dissected from guinea pigs that had been stunned by a blow to the head and bled via the carotid arteries. These procedures were approved by the Animal Welfare Committee of the Flinders University of South Australia.
Intracellular electrophysiology
Neurons in the celiac ganglion were prepared for intracellular electrophysiological recordings as described previously Jobling and Gibbins 1999) . Briefly, celiac ganglia were isolated and placed in a HEPES-buffered balanced salt solution [composition was (in mM) 146 NaCl, 4.7 KCl, 0.6 MgSO 4 , 1.6 NaHCO 3 , 0.13 NaH 2 PO 4 , 2.5 CaCl 2 , 7.8 glucose, and 20 HEPES, buffered to pH 7.3) bubbled with oxygen. Ganglia were pinned to the base of a recording chamber (1 ml) coated with silicone elastomer (Sylgard, Dow Corning, Midland MI), maintained at 35°C, and perfused with physiological solution at 2.5 ml/min. Neurons were impaled with glass microelectrodes filled with 0.5 M KCl, having resistances of 80 -200 M⍀. In some cases, 0.5% wt/vol Neurobiotin (Vector, Burlingame, CA) was included in the electrode filling solution to enable postimpalement visualization of neurons.
Data were recorded using an Axoprobe 1A or an Axoclamp 2B amplifier (Axon Instruments, Burlingame, CA). Voltage and current records were digitized at 1-5 kHz using with either a 1401-Plus A/D converter running Spike2 software (version 3.0, Cambridge Electronic Design, Cambridge, UK) or a Maclab running Chart and Scope software (version 3.6, ADI Instruments, Castle Hill, NSW, Australia). Digitized data were analyzed using Igor Pro (version 3.14, WaveMetrics, Lake Oswego, OR). Changes in membrane potential were determined using either discontinuous current clamp (DCC) or bridge mode. Single-electrode voltage clamp (SEVC) was used to measure currents underlying the AHP. During DCC and SEVC, the headstage was continuously monitored and the cycling frequency adjusted to minimize the effects of electrode capacitance. The cycling frequency was 1.0 -2.0 kHz for DCC and 2-3.5 kHz for SEVC. The tail currents underlying the AHP were measured after suprathreshold voltage steps (10 ms) initiated a single brief "action current" corresponding to an unclamped action potential Jobling et al. 1993; Wang and McKinnon 1995) . Neurons were classified as tonic on the basis of their continuous action potential discharge throughout a depolarizing current injection (250-ms duration). LAH neurons were classified on the basis of a prolonged afterhyperpolarization (Ͼ1 s) following a single action potential evoked by a 10-to 50-ms depolarizing current injection (see Keast et al. 1993; Weems and Szurszewski 1978) .
Drugs used
SP and senktide were obtained from Auspep (Parkville, VIC, Australia). Both agonists were dissolved in distilled H 2 O at a concentration of 1 mM and stored frozen in 10-l aliquots. SP and senktide were made up to their final concentrations in HEPES-buffered salt solution immediately prior to use. They were applied to the preparation by switching the perfusion lines between normal and agonist containing solution for 1 min. SP was routinely used at a concentration of 1 M and senktide at 0.5 M as preliminary observations, and published data for these (Zhao et al. 1995) and other peripheral neurons (Hardwick et al. 1997 ) indicated that these concentrations were close to maximal. SP (1 M) or senktide (0.5 M) could be applied to the preparation every 10 min without any evidence of desensitization (Fig. 1) . In most experiments, senktide and SP were alternately applied at 10-min intervals (Fig. 1 ). Neurons were considered to be responsive to tachykinin agonists if the resting membrane potential depolarized by Ն2 mV, which was the smallest shift that could unambiguously be detected above baseline variance. Additionally, LAH neurons were considered responsive to agonist if the AHP decreased by Ն1 mV 1 s after the action potential. The NK 1 receptor antagonist SR140333 and NK 3 receptor antagonist SR142801 were a generous gift of Sanofi Recherche (Montpellier, France). These were dissolved in dimethylsulfoxide (DMSO) and stored frozen at a con- centration of 10 mM until use. NK receptor antagonists were used at a final concentration of 1 M with all measurements in antagonistcontaining solution made after at least 30 min exposure. Staurosporine, 1-(5-isoquinolinylsulfonyl)-2-methylpiperazine (H7), and N-(2-guanidinoethyl)-5-isoquinolinesulfonamide (HA1004) were obtained from Sigma (Castle Hill, Australia). Bisindolylmaleimide (Bis) was obtained from Calbiochem (La Jolla, CA).
Visualization of NK 1 receptors
Following electrophysiological recording, ganglia were immersed in fixative (0.2% picric acid and 2% formaldehyde in 0.1 M phosphate buffer, pH 7.0) overnight at 4°C. The tissue was cleared of fixative and dehydrated in a graded series of ethanol, three washes of DMSO, and finally in 100% ethanol. The ganglia were infiltrated with polyethylene glycol (PEG, MW 1000; Sigma) at 60°C, under vacuum, for 30 min and then mounted in PEG, MW 1450 (Murphy et al. 1998 ). Sections 30 m thick were cut at room temperature, initially placed into phosphate-buffered saline (PBS), and then incubated in 10% normal donkey serum (NDS) for 30 min. The sections were incubated in primary antiserum containing 10% NDS for 48 h. Immunoreactivity to NK 1 receptors was detected with an antiserum directed toward the intracellular C terminus of the NK 1 receptor. This antiserum does not cross-react with NK 2 or NK 3 receptors (Shigemoto et al. 1993) . Previous studies in the celiac ganglion of guinea pigs showed that the distribution of NK 1 receptor immunoreactivity observed with this antiserum matches the distribution of high-affinity binding sites for SP at NK 1 receptors as determined by high resolution autoradiography (Messenger and Gibbins 1998; Messenger et al. 1999) . The distribution of this NK 1 receptor immunoreactivity was identical to that seen with another antiserum that also was raised against the intracellular portion of the NK 1 receptor see Messenger et al. 1999) . Other primary antisera used were raised against somatostatin (Som), raised in mouse (gift from Dr. J. C. Brown, clone SOMA 08), or SP, raised in rat (clone NC1/34HL, Sera Lab). Primary antisera were washed off in PBS, and the tissue was incubated in speciesspecific secondary antisera raised in donkeys for 1 h. Species-specific secondary antisera were conjugated to Cy3, Cy5, dichlorotriazinylamino fluorescein (DTAF), or 7-amino-4-methylcoumarin-3-acetic acid (AMCA), all obtained from Jackson Immunoresearch Laboratories (West Grove, PA). For visualization of Neurobiotin, streptavidin conjugated to AMCA or Cy5 was used. Previous studies in our laboratory have shown that this dye-filling procedure and the associated intracellular recording of the electrical properties of the neurons does not diminish their immunoreactivity for a range of neuropeptides and enzymes .
Labeled sections were mounted in carbonate-buffered glycerol (pH 8.6), sealed with nail varnish, and examined with an Olympus BX50 epifluorescence microscope, fitted with highly discriminating filters (Chroma Technology). Images were obtained with a Sony monochrome CCD video camera (Model SSC-M370CE) and were captured on a Macintosh PowerPC computer, using NIH Image v1.60b7 software. The images were the average of 16 accumulated frames. Final images were assembled with Adobe Photoshop, version 5.02, adjusting only contrast and brightness. Some images of dye-filled neurons were processed using a blind deconvolution algorithm (AutoDeblur, version 6, AutoQuant Imaging, Watervliet, NY) to maximize the definition of the dendritic arbors.
Statistical analysis
Summary data are presented in the text as means Ϯ SE. Error bars shown in the figures also represent SE. Percentages are expressed with 95% confidence limits derived from the binomial distribution (Rohlf and Sokal 1995) . Data were analyzed using t-tests, repeated-measures ANOVA, or 2 tests using SPSS for Windows (version 9, SPSS, Chicago, IL).
R E S U L T S
Recordings were generally made from LAH or tonic neurons as they account for most of the neurons within the celiac ganglion (Keast et al. 1993; Zhao et al. 1995) . As described previously, LAH neurons were preferentially located in lateral poles of the ganglion, whereas tonic neurons were located medially Keast et al. 1993) .
Proportions of neurons responding to SP and senktide
Perfusion of 1 M SP for 1 min evoked a depolarization in 42% (95% confidence limits: 20 -55%) of tonic neurons. In LAH neurons, the most prominent effect of 1 M SP was a reduction in the amplitude and duration of the AHP (Fig. 1B) , which was accompanied by a depolarization of variable amplitude. Responses to SP (1 M) were observed in 66% (95% confidence limits: 51-79%) of LAH neurons; this was significantly more than the proportion of tonic neurons responding to SP ( 2 ϭ 4.9; df ϭ 1, P Ͻ 0.02). The NK 3 receptor agonist senktide (0.5 M) evoked a depolarization in 51% (95% confidence limits: 37-65%) of tonic neurons and AHP inhibition in 91% (95% confidence limits: 76 -98%) of LAH neurons ( 2 ϭ 12.6; df ϭ 1, P Ͻ 0.001). In neurons where both agonists were tested, 21% of tonic neurons and 24% of LAH neurons responded to senktide but showed no response to SP (Fig. 2 , A-C). Forty percent of tonic neurons failed to respond to either agonist, whereas only 9% of LAH neurons did not respond to either agonist ( 2 ϭ 15.7; df ϭ 3, P Ͻ 0.002, Fig. 2C ).
Relationship between responses to SP and the presence of NK 1 receptor
As described previously, NK 1 -IR was distributed preferentially on neurons within the medial celiac ganglion, where tonic neurons predominate, and no NK 1 -IR was observed on cells in the lateral regions of the ganglion containing predominantly LAH neurons (see Messenger et al. 1999) . To test the relationship between the immunohistochemical and pharmacological identification of NK 1 receptors, individual neurons were tested for a response to 1 M SP and filled with neurobiotin followed by labeling for NK 1 -IR. Fifty percent (6 of 12) of tonic neurons that responded to SP with a depolarization also expressed NK 1 -IR (Figs. 3 and 5Aa) . Only 1 of 21 tonic neurons did not respond to SP but did express NK 1 -IR. The magnitude of the depolarization in response to SP was twice as large in tonic neurons that did express NK 1 -IR (9.3 Ϯ 2.0 mV) compared with neurons that did not express detectable NK 1 -IR (4.3 Ϯ 0.9 mV, P ϭ 0.04).
In contrast to tonic neurons, none of nine LAH neurons that responded to SP with a depolarization and an inhibition of the LAH expressed NK 1 -IR ( 2 ϭ 8.9, df ϭ 3, P ϭ 0.03; Figs. 4 and 5Ab). These proportions of tonic and LAH neurons that showed NK 1 -IR after dye filling were consistent with predictions from our previous immunohistochemical studies ( Messenger et al. 1999) . Furthermore there was no evidence for a significant degree of internalization of NK 1 -IR following stimulation of the neurons with SP (cf. Jenkinson et al. 1999; .
Relationship between responses to SP and SP-IR axons
Most tonic neurons were surrounded by varicose SP-IR axons (Figs. 3 and 5Ba) . However, only 56% of tonic neurons (95% confidence limits: 37-73%) that had SP-IR axons within one cell diameter responded to 1 M SP (Figs. 3D and 5Ba) . In contrast, most LAH neurons (10 of 12) that had SP-IR axons within one cell diameter responded to SP (Figs. 4C and 5Bb ).
Pharmacological analysis of SP-and senktide-evoked responses
Evidence from Zhao and colleagues (1995) suggests that SP selectively activates NK 1 receptors and senktide selectively activates NK 3 receptors within the guinea pig celiac ganglion. Given the lack of correlation between the expression of NK 1 receptor immunoreactivity and the responsiveness of neurons to SP, we decided to use selective NK 1 and NK 3 receptor antagonists to confirm the receptor selectivity of SP and senktide.
LAH NEURONS. The ability of SP to inhibit the AHP in LAH neurons was antagonized by the selective NK 1 receptor antagonist SR140333 (1 M; Fig. 7Ec) . SP reduced the magnitude of the AHP area by 58 Ϯ 12% (n ϭ 4) in control solution (t ϭ 8.1, P ϭ 0.004) but had no effect in the presence of SR140333 (Figs. 6A and 7Ea ), indicating that SP acts via NK 1 receptors. The reduction of AHP area by SP was not affected by the selective NK 3 receptor antagonist SR142801 (n ϭ 3, t ϭ 0.5, P ϭ 0.7, Figs. 6B and 7Eb) .
Senktide (0.5 M) reduced AHP area by 64 Ϯ 9% (n ϭ 4, Fig.  7Ec ). The inhibition of the AHP produced by senktide was not affected by 1 M SR140333 (n ϭ 4, t ϭ 0.3, P ϭ 0.8; Figs. 6Bb  and 7Ec ). In the presence of SR142801 added subsequent to SR140333 (n ϭ 3, Fig. 6 ) or SR142801 alone (n ϭ 1), the effect of senktide was significantly attenuated (F (1,2) ϭ 46.6, P ϭ 0.02; Figs. 6Bc and 7Ec) . These results suggest that senktide is acting through receptors with NK 3 -like pharmacology.
TONIC NEURONS. The depolarization evoked by SP in tonic neurons was reduced in four of five neurons by 79 Ϯ 28% in the presence of 1 M SR140333 (t ϭ 6.2, P ϭ 0.008; Fig. 7, A and   FIG. 2 . Selectivity of tachykinin agonists. Aa: depolarization evoked in a tonic neuron following bath perfusion with 0.5 M senktide (Senk). Ab: SP (1 M) failed to depolarize the same neuron. B: depolarization and AHP inhibition evoked in a LAH neuron. Averages of 3 AHPs in control and agonists (*) were used for the overlays in the insets. Ba: senktide (0.5 M) depolarized this LAH neuron and inhibited the AHP (inset, *). Bb: perfusion with 1 M SP had no effect on this neuron. C: relative numbers of tonic (a) and LAH (b) neurons that responded to SP and senktide. A significantly higher proportion of LAH neurons responded to these peptides compared with tonic neurons ( 2 ϭ 15.7, P Ͻ 0.02).
Da). The response of the remaining neuron was not affected by SR140333. In contrast, SR142801 did not inhibit the SP-evoked depolarization (t ϭ Ϫ2.1, P ϭ 0.1; n ϭ 4, Fig. 7C ). The depolarization evoked by senktide was abolished in the presence of the NK 3 receptor antagonist SR142801 (Fig. 7B) .
Effects of SP and senktide on membrane properties
Depolarizations evoked by SP or senktide in both tonic and LAH neurons were accompanied by an increase in input resistance (current clamp) or decreases in input conductance (voltage clamp; Fig. 8Aa and Ϫ40 mV were evoked in the absence and in the presence of either SP or senktide. Subtraction of the resulting currents in agonist from those in control solution revealed the voltage dependence of SP and senktide inward currents (Fig. 8B) . In three of three tonic and two of two LAH neurons, currents evoked by SP reversed between Ϫ72 and Ϫ98 mV (mean: Ϫ89.0 Ϯ 4.5 mV, n ϭ 5). Senktide-evoked currents in two tonic and one LAH neuron reversed between Ϫ102 and Ϫ110 mV. This observation suggests that both SP and senktide acted predominantly through decreases in K ϩ conductance. Two major calcium activated K ϩ currents underlie the AHP in LAH neurons, I AHP and I sAHP (Sah 1996) . To determine which conductances were decreased during AHP inhibition by SP or senktide, the peak amplitudes of I AHP and I sAHP were measured before and in the presence of these agonists (Fig.  8C) . SP significantly inhibited I sAHP by 62 Ϯ 6% (n ϭ 12, t ϭ 4.4, P Ͻ 0.001) without reducing I AHP (n ϭ 12, t ϭ 0.1, P ϭ 0.9; Fig. 8C, a and c) . Senktide also reduced I sAHP (78 Ϯ 6% reduction, n ϭ 3, t ϭ 4.9, P Ͻ 0.02) but not I AHP (n ϭ 4, t ϭ Ϫ0.3, P ϭ 0.8; Fig. 8C, b and d) . This observation is consistent with the results of Zhao et al. (1995) , who reported that AHP reduction occurred selectively in LAH but not tonic neurons. There was no significant correlation between the magnitude of the reduction in AHP area by SP (n ϭ 11, R ϭ 0.2, P ϭ 0.2) or senktide (n ϭ 9, R ϭ 0.3, P ϭ 0.2) and the level of depolarization evoked by these agonists. Similarly, in voltage clamp, there was no correlation between the SP-evoked inward current and the SP-evoked reduction in I sAHP (n ϭ 10, R ϭ 0.01, P ϭ 0.9).
Effects of protein kinase inhibitors on responses to SP and senktide
Many neuronal effects of tachykinins have been linked to generation of protein kinase C (Bertrand and Galligan 1995; Parker et al. 1997; Takano et al. 1995) . To determine whether responses mediated by SP or senktide were mediated through PKC-dependent pathways, several PKC inhibitors were used. The PKC inhibitor Bis failed to abolish the AHP inhibition mediated by SP or senktide. In four LAH neurons, 1 M SP reduced AHP area by 59 Ϯ 4% in control solution and 51 Ϯ 13% in the presence of 10 M Bis. Senktide reduced AHP area in these neurons by 77 Ϯ 7% in control solution and 80 Ϯ 2% in 10 M Bis. Similarly H7 (10 M, n ϭ 2) or HA1004 (n ϭ 2) did not change the inhibition of I sAHP following SP perfusion. In tonic neurons, the nonspecific protein kinase inhibitor staurosporine (0.1-0.5 M) did not alter the depolarization evoked by SP in tonic neurons (n ϭ 3).
D I S C U S S I O N
We have investigated the distribution of NK 1 receptors using pharmacological, electrophysiological and immunohistochemical techniques in the guinea pig celiac ganglion. Even though the actions of SP appear to be mediated by receptors with the pharmacology of NK 1 receptors, we found little correlation between the expression of immunoreactivity to NK 1 receptors and sensitivity to SP in individual neurons.
Pharmacological identification of NK tachykinin receptors
There is pharmacological evidence for the presence of both the NK 1 and NK 3 subtypes of tachykinin receptors, but not the NK 2 subtype, on neurons of the guinea pig celiac ganglion (Messenger and Gibbins 1998; Zhao et al. 1995 Zhao et al. , 1996 . Actions of SP on tonic and LAH neurons were selectively inhibited by the NK 1 receptor antagonist SR140333, which had no effect on the actions of senktide, a selective NK 3 agonist. SR140333 is a nonpeptide antagonist that is highly selective for NK 1 receptors (Emonds-Alt et al. 1993) . Furthermore this antagonist has been shown to be selective against the guinea pig neuronal NK 1 receptor (Nalivaiko et al. 1997) . These findings support previous experiments by Zhao et al. (1995 Zhao et al. ( , 1996 , who found that responses to SP were inhibited by the NK 1 receptor antagonist GR71251.
Responses to SP were not altered by the selective NK 3 receptor antagonist SR142801. This antagonist has also been shown to be selective at the guinea pig neuronal NK 3 receptor (Nalivaiko et al. 1997) . Further evidence that SP does not activate NK 3 receptors comes from the observation that SP failed to excite many neurons that were markedly excited by senktide. Although Zhao et al. (1995 Zhao et al. ( , 1996 did not use an NK 3 receptor antagonist in their studies, they too found neurons that were responsive to senktide but not SP. Together, these observations suggest that, under the experimental conditions used in this study and that of Zhao et al. (1995 Zhao et al. ( , 1996 , SP does not normally activate NK 3 receptors to any significant degree.
Immunohistochemical localization of NK 1 receptors
NK 1 receptor immunoreactivity was not found on any LAH neurons despite the fact that the majority of these neurons responded to SP. Furthermore, only half the tonic neurons that responded to SP were NK 1 -IR. This is consistent with our previous celiac-ganglion study, which showed that NK 1 -IR was absent from most NPY-containing neurons, that is, those neurons likely to be LAH neurons, and NK 1 -IR was localized to a subset of neurons without NPY, most of which are likely to be tonic neurons (Messenger et al. 1999 ). The results presented here are also consistent with our previous autoradiographic study showing that high-affinity binding sites for SP with pharmacological characteristics of NK 1 receptors were restricted to the medial regions of the celiac ganglion containing predominantly tonic neurons and were absent from the lateral regions of the ganglion containing mainly LAH neurons (Messenger and Gibbins 1998) . On the basis of the consistency of these results, there is no reason to think that prolonged intracellular recording diminished NK 1 -IR in these neurons (see also Gibbins et al. 1999) .
Mismatch between "pharmacological" and "anatomical" NK 1 receptors
These present results explain the apparent anomaly between our previous immunohistochemical study showing a restricted NK 1 receptor distribution and the pharmacological studies of Zhao and colleagues (1995) that suggested a wider distribution of NK 1 receptors. There is clearly a mismatch between the distribution of NK 1 receptors identified pharmacologically versus those identified with immunohistochemistry. A similar situation may occur in the submucosal plexus of the guinea pig ileum, where the majority of neurons responding to NK 1 receptor agonists did not express NK 1 receptor immunoreactivity (Moore et al. 1997) . Furthermore, submucous arterioles that dilate in response to SP via NK 1 receptor activation (Moore et al. 1997) do not express NK 1 -IR (Portbury et al. 1996) . These workers concluded that two variants of the NK 1 receptor were involved and that the receptor responsible for neuronal depolarization was not recognized by NK 1 receptor antibodies.
Subtypes of NK 1 receptors
The "three peptides, three receptors" view of NK receptors has increasingly come into question (see Maggi and Schwarz 1997) . This is particularly apparent with pharmacological studies of NK 1 receptors where the existence of a "septide-sensitive" NK 1 -related receptor has been debated (Glowinski 1995; Jenkinson et al. 1999; Maggi and Schwartz 1997; Petitet et al. 1992) . Moreover, there is evidence for a splice variant of the NK 1 receptor that has a truncated intracellular carboxy terminus (Fong et al. 1992; Kage et al. 1993 ). There are several lines of evidence that a similar form of the NK 1 receptor may transduce the actions of SP on neurons in the celiac ganglion, in particular on the LAH neurons where no NK 1 -IR could be detected. First, because the antisera used in this study are directed against the intracellular carboxy terminus of the conventional NK 1 receptor (Shigemoto et al. 1993 ), they would not recognize a variant that was truncated in this region. Second, unlike the extended form of the receptor (Vigna 1999), the truncated form of the receptor does not show significant desensitization to repeated applications of agonists (Li et al. 1997; Sanders and Le Vine 1996) and probably is not internalized after activation (Böhm et al. 1997) . Consistent with this, neurons in the celiac ganglion responded repeatedly to high concentrations of SP over long periods of time without any signs of desensitization or receptor internalization. This observation, together with the lack of high-affinity SP binding sites on LAH neurons (Messenger and Gibbins 1998) , also is consistent with observations that at least some forms of the truncated receptor have a decreased affinity for SP compared with the conventional NK 1 receptor (Fong et al. 1992) .
The actions of the conventional NK 1 receptor generally are thought to be mediated by G-proteins which are linked to its intracellular domains (Böhm et al. 1997; Roush et al. 1999) . Some of these G proteins can then activate a variety of kinases including PKC and PKA. However, we were unable to block the effects of SP or senktide with a range of protein kinase inhibitors, which are effective against the actions of tachykinin agonists in other types of neurons (Bertrand and Galligan 1995; Parker et al. 1997; Takano et al. 1995) . Once again, these observations are consistent with the presence of a receptor with a truncated intracellular sequence.
Actions of SP and senktide
SP and senktide had identical actions on both tonic and LAH neurons, suggesting that pharmacologically identified NK 1 and NK 3 receptors are transduced through similar pathways to inhibit the same ionic conductances. In sympathetic neurons, SP is known to alter many ionic conductances including suppression of several K ϩ conductances, activation of a nonspecific cation conductance, and inhibition of N-type calcium channels (Adams et al. 1983; Gilbert et al. 1998; Jones 1985; Shapiro and Hille 1993; Vanner et al. 1993) . The depolarization evoked by SP and senktide in both tonic and LAH neurons was associated with a decrease in input resistance with the underlying inward current reversing at around Ϫ100 mV. This suggests that suppression of K ϩ conductances dominates the depolarization evoked by both these agonists in nondissociated FIG. 8. SP and senktide act on similar ionic conductances. Aa: depolarization and action potential discharge in a tonic neuron following SP perfusion. Hyperpolarizing current injections of 0.1-nA amplitude and 250-ms duration were applied at 2-s intervals. Ab: SP-evoked inward current (top) at a holding potential of Ϫ63 mV (RMP for this neuron, bottom). Hyperpolarizing voltage steps of 30-mV amplitude and 250-ms duration were applied at 5-s intervals. The SP evoked current is associated with a decrease in membrane conductance. B: voltage dependence of SP-and senktide-evoked currents in a tonic neuron. Ba: currents evoked by voltage ramps before (black trace) and during (gray trace, asterisk) SP (1 M) perfusion plotted against voltage. Subtracting these current traces shows the voltage dependence of the SP-evoked current. Bb: current records and subtracted senktide-evoked current during voltage ramps before (black trace) and during (gray trace, asterisk) senktide perfusion in the same neuron (as Ba). The voltage dependence of the SP-and senktide-evoked currents are identical. C: inhibition of I sAHP but not I AHP by SP and senktide in LAH neurons. Ca: outward currents (top) evoked following depolarizing voltage steps (10-ms duration) before (black trace) and during (gray trace) 1 M SP perfusion. I AHP peak amplitude occurs immediately following the voltage step, whereas I sAHP peak amplitude occurs at ϳ800 ms (indicated by arrows). celiac ganglion neurons. Our observation that the size of the depolarization was greater in tonic neurons that expressed NK 1 -IR compared with tonic neurons that lacked NK 1 -IR raises the further possibility that both the conventional NK 1 receptor and the form not recognized by the antibody may independently inhibit similar conductances.
The slow AHP in LAH neurons results from activation of a calcium-activated K ϩ current (I sAHP ) (Keast et al. 1993; Sah 1996) . In central neurons, I sAHP is thought to be due to activation of a novel channel with slow kinetics (Sah 1996) . However, in LAH neurons, the slow AHP may result from the simultaneous activation of three separate calcium-activated K ϩ channels: BK, SK, and the novel slow channel (Martinez-Pinna et al. 2000) . In enteric AH neurons, BK-type calcium-activated K ϩ channels contribute to resting membrane potential (Tokimasa and Akasu 1995), suggesting that part of the depolarization to SP in those neurons is due to suppression of this resting current. Although there is some evidence for a contribution of I sAHP to resting membrane potential in LAH neurons (Martinez-Pinna et al. 2000) , it is unlikely that suppression of this current alone accounts for the tachykinin-induced depolarization in these neurons. There was little correlation between the magnitude of AHP reduction by SP or senktide and the amount of depolarization evoked by these agonists. Furthermore in cultured LAH neurons, SP is associated with reductions in M current and an instantaneous leak conductance (Vanner et al. 1993) . Without further experiments involving selective ion channel antagonists, it is difficult to quantify which channels contribute most to membrane depolarization in either LAH or tonic neurons. However, muscarinic depolarization in guinea pig celiac neurons involves suppression of five distinct K ϩ conductances, suggesting that activation of a single G-proteincoupled receptor can have widespread effects in these neurons (Cassell and McLachlan 1987) .
The signal transduction mechanisms utilized by tachykinin receptors in celiac ganglion neurons are not clear. The lack of effect of a range of kinase inhibitors tends to rule out the involvement of PKC and PKA in the tachykinin-mediated suppression of K ϩ conductances in prevertebral sympathetic neurons. In amphibian paravertebral sympathetic neurons where the major effect of SP is suppression of M current, PKC antagonists are also ineffective (Bosma and Hille 1989; Nakajima and Nakajima 1994) . This is similar to the muscarinic suppression of M current in both amphibian and mammalian paravertebral sympathetic neurons where the signal transduction mechanism remains elusive (Marrion 1997).
Conclusions
The immunohistochemical visualization of NK receptors has been a widely used tool for studying neurotransmission mediated by tachykinins. Several studies have reported an apparent mismatch between the distribution of NK 1 receptors and release sites for SP (Liu et al. 1994; Messenger et al. 1999; Nakaya et al. 1994) and have suggested that SP may act primarily via volume transmission. However, if there is a population of NK 1 -like receptors that are not seen by the current range of antisera, the occurrence of volume transmission by tachykinins may not be as widespread as predicted by those results. Indeed in the present study, the good correlation between the presence of functionally identified NK 1 receptors and nearby SP-IR fibers implies that it is not necessary to evoke the concept of volume transmission for SP in the celiac ganglion. Further studies will be required to determine the distribution and functional significance of a truncated form of tachykinin receptor that seems to be responsible for mediating actions of tachykinins in mammalian sympathetic neurons.
